Thamara Perera, Hynek Mergental, Barney Stephenson, Garrett R. Roll, Hentie Cilliers, Richard Liang, Roberta Angelico, Stefan Hubscher, Desley A. Neil, Gary Reynolds, John Isaac, David A. Adams, Simon Afford, Darius F. Mirza, Paolo Muiesan – 13 November 2015
Francis Y. Yao, Nicholas Fidelman – 11 November 2015 – Down‐staging of hepatocellular carcinoma prior to liver transplantation (LT) has generated a lot of interest in recent years and has been identified in two recent national conferences on hepatocellular carcinoma as one of the priorities for research. Down‐staging is defined as reduction in the tumor burden using local regional therapy specifically to meet acceptable criteria for LT.
Jeffrey Cui, Elhamy Heba, Carolyn Hernandez, William Haufe, Jonathan Hooker, Michael P. Andre, Mark A. Valasek, Hamed Aryafar, Claude B. Sirlin, Rohit Loomba – 11 November 2015 – Magnetic resonance elastography (MRE), an advanced magnetic resonance–based imaging technique, and acoustic radiation force impulse (ARFI), an ultrasound‐based imaging technique, are accurate for diagnosing nonalcoholic fatty liver disease (NAFLD) fibrosis. However, no head‐to‐head comparisons between MRE and ARFI for diagnosing NAFLD fibrosis have been performed.
Francis Y. Yao, Nicholas Fidelman – 11 November 2015 – Down‐staging of hepatocellular carcinoma prior to liver transplantation (LT) has generated a lot of interest in recent years and has been identified in two recent national conferences on hepatocellular carcinoma as one of the priorities for research. Down‐staging is defined as reduction in the tumor burden using local regional therapy specifically to meet acceptable criteria for LT.
Stacey S. Huppert – 11 November 2015
Marina Serper, Gina Choi, Kimberly A. Forde, David E. Kaplan – 11 November 2015 – Previous studies have identified gaps in hepatitis B care. The objectives of this study were to evaluate the delivery of care among a national cohort of US veterans with chronic hepatitis B infection and examine risk factors for adverse clinical outcomes.
Francis Y. Yao, Nicholas Fidelman – 11 November 2015 – Down‐staging of hepatocellular carcinoma prior to liver transplantation (LT) has generated a lot of interest in recent years and has been identified in two recent national conferences on hepatocellular carcinoma as one of the priorities for research. Down‐staging is defined as reduction in the tumor burden using local regional therapy specifically to meet acceptable criteria for LT.
Jan‐Peter Sowa, Christian Dominik Fingas, Ali Canbay – 6 November 2015
Michael J.R. Desborough, Vipul Jairath – 6 November 2015
Lesley De Pietri, Marcello Bianchini, Guadalupe Garcia‐Tsao, Erica Villa – 6 November 2015